{"database": "lobbying", "table": "lobbying_activities", "rows": [[1980669, "831df6fc-5d07-42b2-855e-b4d52cfe7ceb", "2T", "FAEGRE BAKER DANIELS CONSULTING", 34158, "BIODELIVERY SERVICES INTERNATIONAL, INC.", 2017, "second_quarter", "HCR", "Access to innovative therapies for addiction treatment", "HOUSE OF REPRESENTATIVES,SENATE", 0, 1, "2017-05-05T10:19:07.857000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1980669"], "units": {}, "query_ms": 0.2880740212276578, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}